Stock listing
ASX:CBL Control Bionics Ltd. Share Price
Follow Control Bionics Ltd. into a list and get an email when it puts out news.
Share price · ASX:CBL
$0.042 AUD -0.007 (-14.3%)
Close on Nov 20, 2026
- Day range
- $0.042 – $0.044 AUDNov 20, 2026
- Volume
- 1.74M sharesNov 20, 2026
- Market cap
- $22.85M AUDAt the close on Nov 20, 2026 · price × 544.1M shares outstanding
- 52-week range
- $0.042 – $0.095 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $24,872 AUDMedian day 230,911 shares · 3 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:CBL · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.042 | -0.007 | -14.3% | $0.044 | $0.044 | $0.042 | 1,735,745 | |
| $0.049 | +0.001 | +2.1% | $0.048 | $0.049 | $0.048 | 177,708 | |
| $0.048 | -0.003 | -5.9% | $0.050 | $0.050 | $0.048 | 695,862 | |
| $0.051 | -0.002 | -3.8% | $0.053 | $0.053 | $0.051 | 308,541 | |
| $0.053 | -0.001 | -1.9% | $0.053 | $0.053 | $0.053 | 358,516 | |
| $0.054 | +0.004 | +8.0% | $0.055 | $0.055 | $0.052 | 1,010,254 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 11,000 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.051 | $0.049 | 311,970 | |
| $0.050 | +0.001 | +2.0% | $0.052 | $0.052 | $0.048 | 96,172 | |
| $0.049 | 0.000 | 0.0% | $0.049 | $0.049 | $0.049 | 5,000 | |
| $0.049 | 0.000 | 0.0% | $0.049 | $0.049 | $0.049 | 5,000 | |
| $0.049 | 0.000 | 0.0% | $0.049 | $0.049 | $0.049 | 29,860 | |
| $0.049 | -0.001 | -2.0% | $0.048 | $0.050 | $0.048 | 210,714 | |
| $0.050 | -0.002 | -3.8% | $0.050 | $0.050 | $0.050 | 662,057 | |
| $0.052 | +0.003 | +6.1% | $0.050 | $0.052 | $0.049 | 240,667 | |
| $0.049 | 0.000 | 0.0% | $0.050 | $0.051 | $0.049 | 1,371,182 | |
| $0.049 | -0.004 | -7.5% | $0.053 | $0.053 | $0.049 | 2,278,967 | |
| $0.053 | 0.000 | 0.0% | $0.053 | $0.053 | $0.053 | 87,434 | |
| $0.053 | -0.003 | -5.4% | $0.053 | $0.053 | $0.053 | 15,878 | |
| $0.056 | +0.002 | +3.7% | $0.054 | $0.056 | $0.053 | 306,352 | |
| $0.054 | 0.000 | 0.0% | $0.056 | $0.056 | $0.054 | 162,373 | |
| $0.054 | -0.002 | -3.6% | $0.056 | $0.056 | $0.053 | 1,054,018 | |
| $0.056 | -0.002 | -3.4% | $0.059 | $0.059 | $0.054 | 1,058,665 | |
| $0.058 | 0.000 | 0.0% | $0.058 | $0.058 | $0.058 | 0 | |
| $0.058 | -0.002 | -3.3% | $0.060 | $0.060 | $0.058 | 130,000 | |
| $0.060 | -0.003 | -4.8% | $0.063 | $0.063 | $0.060 | 523,861 | |
| $0.063 | -0.002 | -3.1% | $0.066 | $0.066 | $0.063 | 378,219 | |
| $0.065 | 0.000 | 0.0% | $0.065 | $0.065 | $0.065 | 10,000 | |
| $0.065 | +0.002 | +3.2% | $0.066 | $0.066 | $0.065 | 517,227 | |
| $0.063 | -0.003 | -4.5% | $0.066 | $0.066 | $0.063 | 103,000 | |
| $0.066 | +0.001 | +1.5% | $0.064 | $0.066 | $0.063 | 253,785 | |
| $0.065 | +0.001 | +1.6% | $0.066 | $0.066 | $0.065 | 400,629 | |
| $0.064 | +0.004 | +6.7% | $0.060 | $0.064 | $0.060 | 189,928 | |
| $0.060 | -0.001 | -1.6% | $0.060 | $0.060 | $0.060 | 141,590 | |
| $0.061 | -0.001 | -1.6% | $0.062 | $0.062 | $0.061 | 204,634 | |
| $0.062 | 0.000 | 0.0% | $0.062 | $0.062 | $0.058 | 493,553 | |
| $0.062 | 0.000 | 0.0% | $0.062 | $0.062 | $0.062 | 10,000 | |
| $0.062 | +0.006 | +10.7% | $0.056 | $0.062 | $0.056 | 477,153 | |
| $0.056 | -0.001 | -1.8% | $0.056 | $0.056 | $0.056 | 100,000 | |
| $0.057 | -0.001 | -1.7% | $0.056 | $0.057 | $0.056 | 413,205 | |
| $0.058 | 0.000 | 0.0% | $0.058 | $0.059 | $0.058 | 421,138 | |
| $0.058 | 0.000 | 0.0% | $0.058 | $0.059 | $0.058 | 221,154 | |
| $0.058 | -0.003 | -4.9% | $0.062 | $0.062 | $0.058 | 535,322 | |
| $0.061 | -0.001 | -1.6% | $0.061 | $0.061 | $0.061 | 5,000 | |
| $0.062 | +0.002 | +3.3% | $0.061 | $0.062 | $0.061 | 5,071 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 21,666 | |
| $0.060 | -0.001 | -1.6% | $0.060 | $0.060 | $0.060 | 22,085 | |
| $0.061 | 0.000 | 0.0% | $0.061 | $0.061 | $0.059 | 837,943 | |
| $0.061 | 0.000 | 0.0% | $0.061 | $0.061 | $0.061 | 0 | |
| $0.061 | +0.001 | +1.7% | $0.060 | $0.061 | $0.060 | 140,006 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | -0.002 | -3.2% | $0.060 | $0.060 | $0.059 | 258,175 | |
| $0.062 | +0.004 | +6.9% | $0.059 | $0.062 | $0.059 | 214,999 | |
| $0.058 | -0.001 | -1.7% | $0.058 | $0.060 | $0.058 | 367,203 | |
| $0.059 | -0.003 | -4.8% | $0.060 | $0.060 | $0.059 | 110,001 | |
| $0.062 | +0.004 | +6.9% | $0.063 | $0.063 | $0.062 | 55,552 | |
| $0.058 | -0.003 | -4.9% | $0.060 | $0.060 | $0.058 | 334,879 | |
| $0.061 | +0.001 | +1.7% | $0.062 | $0.062 | $0.061 | 69,343 | |
| $0.060 | +0.002 | +3.4% | $0.060 | $0.060 | $0.060 | 50,944 | |
| $0.058 | -0.002 | -3.3% | $0.058 | $0.060 | $0.058 | 745,009 | |
| $0.060 | -0.001 | -1.6% | $0.065 | $0.065 | $0.060 | 4,922,270 | |
| $0.061 | +0.002 | +3.4% | $0.060 | $0.061 | $0.060 | 145,482 | |
| $0.059 | +0.001 | +1.7% | $0.063 | $0.063 | $0.057 | 491,456 | |
| $0.058 | -0.002 | -3.3% | $0.060 | $0.060 | $0.058 | 296,570 | |
| $0.060 | 0.000 | 0.0% | $0.061 | $0.061 | $0.059 | 704,803 | |
| $0.060 | 0.000 | 0.0% | $0.061 | $0.063 | $0.059 | 1,810,561 |
- Ticker
- ASX:CBL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Oct 28, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Latest deck · Nov 18, 2026
Bell Potter Healthcare Conference 2026
Conference · 7 slides
Latest news
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 28, 2026
Closed $0.049 (0.0%) on Oct 29, 2026
Medicare Billing Code Secured for NextLevel Speech Devices
Aug 26, 2026
Closed $0.06 (-1.6%) on Aug 27, 2026
NeuroStrip secures MHRA registration
Aug 24, 2026
Closed $0.059 (+1.7%) on Aug 25, 2026
US FDA Registration and Device Listing for NeuroStrip
Aug 3, 2026
Closed $0.064 (-1.5%) on Aug 4, 2026
Commercial momentum builds across both platform pillars
Jul 30, 2026
Closed $0.064 (-3.0%) on Jul 31, 2026
Completion of Placement
Jun 24, 2026
Closed $0.085 (-2.3%) on Jun 25, 2026
Pause in Trading
Jun 23, 2026
Closed $0.087 (0.0%) on Jun 24, 2026
Commercial Momentum Presentation
Jun 3, 2026
Closed $0.07 (+18.6%) on Jun 4, 2026
German Statutory Reimbursement Listing for NeuroNode
Mar 3, 2026
Closed $0.063 (+14.5%) on Mar 4, 2026
Joint venture with NextLevel Assistive Technology
Feb 25, 2026
Closed $0.056 (-6.7%) on Feb 26, 2026
Control Bionics Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 17 in the last 12 months · 84 in all · newest Oct 28, 2026 · oldest 2016
- Decks
- 25 decks · latest Nov 18, 2026
Valuation
EV/sales 4.5× against a median of 1.2×: 8th lowest of 9 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $21.40M AUD
- P/E
- Loss
- EV/sales
- 4.5×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 3.6×
- Gross margin
- −86.8%
- Operating margin
- −153.0%
- Net margin
- −152.4%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Control Bionics Ltd. · ASX:CBL | US$15.13M | US$14.16M | n/a | 4.5× | n/a | 3.6× | −152.4% | 0.1× | n/a |
| Modular Medical, Inc. · NASDAQ:MODD | US$16.36M | US$11.26M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | 2.27 |
| European Medical Solutions. · EURONEXT:ALEMS | US$16.25M | US$33.71M | 8.1× | 0.6× | 6.3× | 1.1× | 3.7% | 1.5× | n/a |
| Picard Medical, Inc. · AMEX:PMI | US$15.88M | US$17.30M | n/a | 3.3× | n/a | 11.9× | −371.7% | 1.1× | 0.41 |
| SG Healthcare Co., Ltd. · KRX:398120 | US$15.78M | US$11.93M | 19.3× | 0.6× | n/a | 0.9× | 4.2% | 0.0× | n/a |
| Careplus Group Bhd. · MYX:CAREPLS | US$15.50M | US$20.64M | n/a | 0.8× | n/a | 0.3× | −11.1% | 0.1× | n/a |
| HeartBeam, Inc. · NASDAQ:BEAT | US$15.50M | US$9.44M | n/a | n/a | n/a | 2.4× | n/a | 0.0× | 1.93 |
| Lifecare ASA · OSL:LIFE | US$15.21M | US$11.43M | n/a | 175× | n/a | 2.7× | n/a | 0.0× | n/a |
| Micro-X Ltd. · ASX:MX1 | US$14.45M | US$16.66M | n/a | 1.7× | n/a | 4.5× | −65.5% | 1.3× | n/a |
| Perimeter Medical Imaging AI Inc · TSXV:PINK | US$14.45M | US$8.00M | n/a | 3.8× | n/a | 3.5× | −478.7% | 0.0× | 1.55 |
| CVRx, Inc. · NASDAQ:CVRX | US$14.27M | US$14.18M | n/a | 0.2× | n/a | 1.0× | −88.3% | 4.2× | 1.28 |
| Median of the others | US$15.50M | US$13.06M | 13.7× | 1.2× | 6.3× | 1.9× | −65.5% | 0.1× | 1.55 |
Team and board
Officers
| Officer | Role |
|---|---|
| Jeremy Steele | Chief Executive Officer |
| Shannon Boothroyd | Chief Financial Officer |
| Todd Tyler | President, North America |
| Brett Crowley | Company Secretary |
| Chris Feighner | Director of Operations |
| James Schorey | Chief Technical Officer |
| Jeffrey Kitchen | Director of Product |
Board
| Director | Role |
|---|---|
| Stephen Rix | Chairman |
| Damian Lismore | Non-Executive Director |
| Nicholas Opie | Non-Executive Director |
| Rob Heard | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2025 | Aug 28, 2025 | +2.7% |
| Q4 2024 | Feb 25, 2025 | −7.1% |
| Q4 2022 | Feb 23, 2023 | +6.2% |
| Q2 2022 | Aug 24, 2022 · Before open | −1.0% |
| Q4 2021 | Feb 22, 2022 · After close | −10.0% |
| Q2 2021 | Aug 25, 2021 · After close | −2.8% |
| Q4 2020 | Feb 24, 2021 · After close | 0.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Bell Potter Healthcare Conference 2026 | Conference | 7 slides | Nov 18, 2026 |
| Shareholder Meeting (October 2026) | Shareholder meeting | 29 slides | Oct 13, 2026 |
| LSI Asia July 2026 | Conference | 12 slides | Jul 1, 2026 |
| Corporate Update (June 2026) | Corporate update | 22 slides | Jun 4, 2026 |
| Investor Presentation (April 2026) | Investor deck | 21 slides | May 5, 2026 |
| Investor Presentation (February 2026) | Investor deck | 8 slides | Feb 26, 2026 |
| Shareholder Meeting (November 2025) | Shareholder meeting | 31 slides | Nov 25, 2025 |
| Investor Presentation (November 2025) | Investor deck | 16 slides | Nov 13, 2025 |
| Coffee Microcaps Meeting (November 2024) | Conference | 21 slides | Nov 8, 2024 |
| Shareholder Meeting (October 2024) | Shareholder meeting | 22 slides | Oct 10, 2024 |
All 25 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2024) | Investor deck | 36 slides | Sep 19, 2024 |
| Techknow Conference 2024 | Conference | 13 slides | Jul 31, 2024 |
| United Nations AI for Good Summit (May 2024) | Conference | 17 slides | May 31, 2024 |
| Investor Presentation (April 2024) | Investor deck | 40 slides | Apr 23, 2024 |
| Shareholder Meeting (October 2023) | Shareholder meeting | 27 slides | Oct 10, 2023 |
| Bioshares Biotech Summit (July 2023) | Conference | 11 slides | Jul 24, 2023 |
| Investor Presentation (May 2023) | Investor deck | 18 slides | May 30, 2023 |
| Investor Presentation (April 2023) | Investor deck | 13 slides | Apr 19, 2023 |
| Shareholder Meeting (October 2022) | Shareholder meeting | 30 slides | Oct 6, 2022 |
| Shareholder Meeting (October 2022) | Shareholder meeting | 15 slides | Oct 6, 2022 |
| Morgans Technology Conference 2021 | Conference | 22 slides | Nov 24, 2021 |
| Investor Presentation (October 2021) | Investor deck | 16 slides | Oct 22, 2021 |
| Shareholder Meeting (October 2021) | Shareholder meeting | 34 slides | Oct 13, 2021 |
| H1 FY2021 Earnings Presentation | Earnings | 24 slides | Feb 25, 2021 |
| FY2016 Earnings Presentation | Earnings | 33 slides | Feb 24, 2017 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of new ordinary shares Announced: about A$9.5M · A$0.075 a share · Bell Potter Securities Limited +1 Dealers: Bell Potter Securities Limited (co-lead), Unified Capital Partners Pty Ltd (co-lead) Buyers: Stephen Rix (2,040,000 shares, subject to shareholder approval); Jeremy Steele (1,160,000 shares, subject to shareholder approval); Nicholas Opie (400,000 shares, subject to shareholder approval); Robert Heard (333,333 shares, subject to shareholder approval); Damian Lismore (320,000 shares, subject to shareholder approval) Insiders: Tranche 2 includes approximately 4.3 million shares (4,253,333) to directors, subject to shareholder approval Use of proceeds: Commercialisation initiatives and working capital | Jun 25, 2026 | US$6.57M |
| Share purchase plan of new shares Announced: up to A$500,000 · A$0.075 a share Use of proceeds: Commercial expansion, platform and medtech development, strategic initiatives, working capital and offer costs | Jun 25, 2026 | US$345,572 |
| Private placement of new fully paid ordinary shares Announced: A$3.25M · A$0.065 a share Buyers: Reitham Equity GmbH (anchored the placement) Use of proceeds: Working capital to accelerate commercialisation of core assistive technology products and emerging neurotechnology markets | Dec 1, 2025 | US$2.13M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in AUD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.77M | 6.14M | 5.35M | 5.64M | 4.50M | 4.09M | 3.10M | 781.4K | 805.4K | 311.3M |
| Cost of revenue | 8.91M | 2.03M | 1.45M | 1.93M | 7.42M | 1.43M | 2.88M | 1.42M | 1.09M | |
| Gross profit | -4.14M | 4.11M | 3.90M | 3.71M | -2.91M | 2.50M | 215.5K | -634.1K | -285.0K | 311.3M |
| Research and development | 1.24M | 1.07M | 1.71M | 231.0K | 328.9K | 166.2K | 68.3K | 361.2K | 79.0K | |
| Selling, general and administrative | 6.44M | 1.54M | 5.67M | 5.29M | 4.91M | 3.33M | 786.3K | 137.9K | 71.8K | 30.3M |
| Operating income | -7.29M | -5.83M | -5.93M | -5.21M | -6.01M | -2.95M | -1.20M | -2.05M | -1.06M | 54.9M |
| Depreciation and amortization | 792.5K | 986.5K | 843.2K | 480.4K | 507.9K | 198.5K | 115.2K | 9.22K | 4.71K | 6.32M |
| EBITDA | -6.50M | -4.84M | -5.09M | -4.73M | -5.51M | -2.75M | -1.09M | -2.04M | -1.05M | 61.2M |
| Interest expense | 85.0K | 109.0K | 56.3K | 21.3K | 10.7K | 70.4K | 3.33K | 436 | 1.16K | 13.4M |
| Income before tax | -7.72M | -6.11M | -5.91M | -5.63M | -6.10M | -3.55M | -1.11M | -2.05M | -1.06M | 42.4M |
| Income tax | -454.2K | -426.6K | -850.4K | -412.8K | -338.5K | -116.3K | -103.0K | -114.9K | -85.2K | 12.9M |
| Net income | -7.27M | -6.11M | -5.91M | -5.63M | -6.11M | -3.55M | -1.01M | -1.93M | -972.5K | 28.6M |
| Earnings per share, basic | -0.02 | -0.02 | -0.04 | -0.06 | -0.06 | -0.04 | -0.01 | -0.02 | -0.01 | 0.13 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.08M | 594.7K | 980.8K | 935.5K | 5.21M | 12.3M | 15.6M | 798.9K | 1.84M | 388.4M |
| Short-term investments | 77.9K | 77.9K | 56.2K | 56.2K | 13.1K | 7.32M | ||||
| Receivables | 1.35M | 1.40M | 2.19M | 1.78M | 1.76M | 1.12M | 317.0K | 289.2K | 256.1K | 334.9M |
| Inventory | 451.6K | 409.6K | 404.1K | 801.9K | 924.0K | 269.4K | 179.0K | 180.5K | 88.0K | |
| Current assets | 4.18M | 3.17M | 3.76M | 3.90M | 8.61M | 13.7M | 16.1M | 1.27M | 2.18M | 730.6M |
| Property, plant and equipment | 844.0K | 1.22M | 720.2K | 711.5K | 534.1K | 287.3K | 31.4K | 9.77K | ||
| Goodwill | 752.1K | 149.0M | ||||||||
| Total assets | 9.05M | 8.23M | 9.03M | 8.70M | 13.4M | 18.4M | 20.5M | 5.43M | 6.31M | 1.16B |
| Accounts payable | 904.1K | 1.39M | 609.7K | 1.17M | 429.3K | 459.6K | 191.0K | 253.6K | 121.8K | 117.1K |
| Current liabilities | 2.72M | 2.55M | 2.40M | 1.56M | 1.36M | 1.17M | 364.0K | 375.8K | 215.9K | 13.0M |
| Long-term debt | 0 | 235.7K | ||||||||
| Total debt | 618.9K | 435.4K | 961.7K | 128.5K | 284.8K | 14.9K | 282.1K | 38.5M | ||
| Total liabilities | 2.73M | 2.72M | 2.76M | 1.58M | 1.51M | 1.19M | 387.0K | 375.8K | 215.9K | 876.4M |
| Shareholders' equity | 6.31M | 5.51M | 6.27M | 7.15M | 11.9M | 17.2M | 20.1M | 5.05M | 6.09M | 281.4M |
| Shares outstanding | 371.2M | 264.1M | 159.4M | 100.1M | 94.6M | 92.6M | 92.4M | 92.4M | 92.4M | 223.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.75M | -4.27M | -4.91M | -4.53M | -6.89M | -3.99M | -864.0K | -1.95M | -970.8K | |
| Capital spending | -10.0K | -302.3K | -473.1K | -457.5K | -147.7K | -53.4K | -301.8K | -35.6K | -14.3K | -3.05M |
| Free cash flow | -5.76M | -4.57M | -5.38M | -4.98M | -5.75M | -4.04M | -1.17M | -1.98M | -985.2K | -3.05M |
| Cash from investing | -269.8K | -744.8K | -473.1K | -457.5K | -147.7K | -53.4K | -301.8K | -35.6K | -14.3K | 54.6M |
| Cash from financing | 7.49M | 4.63M | 5.43M | 706.4K | -87.3K | 14.9M | 1.79M | 933.4K | 2.63M | 54.6M |
| Dividends paid | -48.5K | -16.2M | ||||||||
| Share buybacks | -220.8K | 5.41M | -114.5K | 862.8K | 14.1K | -715.3K | 1.58M | 933.4K | 2.63M | -4.15M |
| Change in cash | 1.48M | -386.0K | 45.3K | -4.28M | -7.12M | 10.9M | 629.5K | -1.04M | 1.65M | 103.7M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 28, 2026 | Quarterly report | ASX |
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 28, 2026 | Quarterly report | ASX |
| Medicare Billing Code Secured for NextLevel Speech Devices | Aug 26, 2026 | Operations update | ASX |
| NeuroStrip secures MHRA registration | Aug 24, 2026 | Operations update | ASX |
| US FDA Registration and Device Listing for NeuroStrip | Aug 3, 2026 | Operations update | ASX |
| Commercial momentum builds across both platform pillars | Jul 30, 2026 | Operations update | ASX |
| Completion of Placement | Jun 24, 2026 | Financing | ASX |
| Pause in Trading | Jun 23, 2026 | Trading halt or suspension | ASX |
| Commercial Momentum Presentation | Jun 3, 2026 | Operations update | ASX |
| German Statutory Reimbursement Listing for NeuroNode | Mar 3, 2026 | Operations update | ASX |
All 84 filings
Cap table
Built by 6ix from Control Bionics Ltd.’s releases · as of Jun 25, 2026
- Common shares
- 544,132,796
- Fully diluted
- 544,132,796
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 544,132,796 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 544,132,796 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Brett Crowley | Company Secretary · Since at least Nov 5, 2026 |
| Chris Feighner | Director of Operations · Since at least Nov 4, 2026 |
| Damian Lismore | Non-Executive Director · Since at least Nov 5, 2026 |
| James Schorey | Chief Technical Officer · Since at least Nov 4, 2026 |
| Jeffrey Kitchen | Director of Product · Since at least Nov 4, 2026 |
| Jeremy Steele | Chief Executive Officer · Since at least Nov 5, 2026 |
| Nicholas Opie | Non-Executive Director · Since at least Nov 5, 2026 |
| Rob Heard | Non-Executive Director · Since at least Nov 4, 2026 |
| Shannon Boothroyd | Chief Financial Officer · Since at least Nov 4, 2026 |
| Stephen Rix | Chairman · Since at least Nov 5, 2026 |
All 11 people
| Person | Seat |
|---|---|
| Todd Tyler | President, North America · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Control Bionics Ltd.